First Capital Advisors Group’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

First Capital Advisors Group’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$485	Buy	+17	New	+$679	﹤0.01%	922

Other funds holding TBIO

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Capital Advisors Group's TBIO Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in Telesis Bio, Inc. Common Stock (TBIO) in Q2 2023: 17 shares worth $485. The stake represents ﹤0.01% of the portfolio and ranks #922 among its holdings.

29 funds tracked by Wall St. Rank hold TBIO as of Q2 2023.

First Capital Advisors Group held 17 shares of Telesis Bio, Inc. Common Stock worth $485 as of Q2 2023.
Telesis Bio, Inc. Common Stock was a new First Capital Advisors Group position in Q2 2023.
Telesis Bio, Inc. Common Stock made up ﹤0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #922 holding.
29 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.